Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2016 (2016), Article ID 9473158, 8 pages
http://dx.doi.org/10.1155/2016/9473158
Research Article

Lipid Profile in Adolescent Girls with Type 1 Diabetes Mellitus and Hyperandrogenemia

1Department of Pediatrics and Pediatric Endocrinology, School of Medicine in Katowice, Medical University of Silesia, Medykow Street 16, 40-752 Katowice, Poland
2Department of Pediatric Diabetes, School of Medicine in Katowice, Medical University of Silesia, Medykow Street 16, 40-752 Katowice, Poland
3Department of Woman’s Health, School of Medicine in Katowice, Medical University of Silesia, Medykow Street 12, 40-752 Katowice, Poland
4Department of Instrumental Analysis, School of Pharmacy in Sosnowiec, Medical University of Silesia, Jednosci Street 8, 41-200 Sosnowiec, Poland

Received 17 January 2016; Revised 30 March 2016; Accepted 6 April 2016

Academic Editor: Mario Maggi

Copyright © 2016 Agnieszka Zachurzok et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Guy, L. Ogden, R. P. Wadwa et al., “Lipid and lipoprotein profiles in youth with and without type 1 diabetes: the SEARCH for diabetes in youth case-control study,” Diabetes Care, vol. 32, no. 3, pp. 416–420, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. L. Machnica, G. Deja, J. Polanska, and P. Jarosz-Chobot, “Blood pressure disturbances and endothelial dysfunction markers in children and adolescents with type 1 diabetes,” Atherosclerosis, vol. 237, no. 1, pp. 129–134, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. I. R. Pirwany, R. Fleming, I. A. Greer, C. J. Packard, and N. Sattar, “Lipids and lipoprotein subfractions in women with PCOS: relationship to metabolic and endocrine parameters,” Clinical Endocrinology, vol. 54, no. 4, pp. 447–453, 2001. View at Publisher · View at Google Scholar · View at Scopus
  4. R. A. Wild, “Dyslipidemia in PCOS,” Steroids, vol. 77, no. 4, pp. 295–299, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. E. Codner, N. Soto, P. Lopez et al., “Diagnostic criteria for polycystic ovary syndrome and ovarian morphology in women with type 1 diabetes mellitus,” Journal of Clinical Endocrinology and Metabolism, vol. 91, no. 6, pp. 2250–2256, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. H. F. Escobar-Morreale, B. Roldán, R. Barrio et al., “High prevalence of the polycystic ovary syndrome and hirsutism in women with type 1 diabetes mellitus,” Journal of Clinical Endocrinology and Metabolism, vol. 85, no. 11, pp. 4182–4187, 2000. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Zachurzok, G. Deja, A. Gawlik, A. Drosdzol-Cop, and E. Małecka-Tendera, “Hyperandrogenism in adolescent girls with type 1 diabetes mellitus treated with intensive and continuous subcutaneous insulin therapy,” Endokrynologia Polska, vol. 64, no. 2, pp. 121–128, 2013. View at Google Scholar · View at Scopus
  8. I. C. Bouzas, S. A. Cader, L. Leão, M. C. Kuschnir, and C. Braga, “Menstrual cycle alterations during adolescence: early expression of metabolic syndrome and polycystic ovary syndrome,” Journal of Pediatric and Adolescent Gynecology, vol. 27, no. 6, pp. 335–341, 2014. View at Publisher · View at Google Scholar
  9. S. F. Witchel, S. Oberfield, R. L. Rosenfield et al., “The diagnosis of polycystic ovary syndrome during adolescence,” Hormone Research in Paediatrics, vol. 83, no. 6, pp. 376–389, 2015. View at Publisher · View at Google Scholar · View at Scopus
  10. R. Amin, C. Schultz, K. Ong et al., “Low IGF-I and elevated testosterone during puberty in subjects with type 1 diabetes developing microalbuminuria in comparison to normoalbuminuric control subjects: the Oxford Regional Prospective study,” Diabetes Care, vol. 26, no. 5, pp. 1456–1461, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. E. Carmina, S. E. Oberfield, and R. A. Lobo, “The diagnosis of polycystic ovary syndrome in adolescents,” American Journal of Obstetrics and Gynecology, vol. 203, no. 3, pp. 201.e1–201.e5, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. W. T. Friedewald, R. I. Levy, and D. S. Fredrickson, “Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge,” Clinical Chemistry, vol. 18, no. 6, pp. 499–502, 1972. View at Google Scholar · View at Scopus
  13. K. C. Donaghue, R. P. Wadwa, L. A. Dimeglio et al., “ISPAD clinical practice consensus guidelines 2014 compendium: microvascular and macrovascular complications in children and adolescents,” Pediatric Diabetes, vol. 15, pp. 257–269, 2014. View at Google Scholar
  14. M. J. Rewers, K. Pillay, C. de Beaufort et al., “ISPAD Clinical Practice Consensus Guidelines 2014 Compendium: assessment and monitoring of glycemic control in children and adolescents with diabete,” Pediatric Diabetes, vol. 15, no. 20, pp. 102–114, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. E. Lerchbaum, V. Schwetz, T. Rabe, A. Giuliani, and B. Obermayer-Pietsch, “Hyperandrogenemia in polycystic ovary syndrome: exploration of the role of free testosterone and androstenedione in metabolic phenotype,” PLoS ONE, vol. 9, no. 10, Article ID e108263, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. R. A. Wild and M. J. Bartholomew, “The influence of body weight on lipoprotein lipids in patients with polycystic ovary syndrome,” American Journal of Obstetrics and Gynecology, vol. 159, no. 2, pp. 423–427, 1988. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Dabas, S. Yadav, and V. K. Gupta, “Lipid profile and correlation to cardiac risk factors and cardiovascular function in type 1 adolescent diabetics from a developing country,” International Journal of Pediatrics, vol. 2014, Article ID 513460, 7 pages, 2014. View at Publisher · View at Google Scholar
  18. X. Gaete, G. Iñiguez, J. Linares, A. Avila, and V. Mericq, “Cortisol hyporesponsiveness to the low dose ACTH test is a frequent finding in a pediatric population with type 1 diabetes mellitus,” Pediatric Diabetes, vol. 14, no. 6, pp. 429–434, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. N. Tagawa, M. Ohta, N. Nakamura et al., “Serum concentrations of delta 5-3 β-hydroxysteroids in type 2 diabetes mellitus,” Biological and Pharmaceutical Bulletin, vol. 25, no. 12, pp. 1634–1638, 2002. View at Publisher · View at Google Scholar
  20. K. Meyer, J. Deutscher, M. Anil, A. Berthold, M. Bartsch, and W. Kiess, “Serum androgen levels in adolescents with type 1 diabetes: relationship to pubertal stage and metabolic control,” Journal of Endocrinological Investigation, vol. 23, no. 6, pp. 362–368, 2000. View at Publisher · View at Google Scholar · View at Scopus
  21. E. Codner and H. F. Escobar-Morreale, “Hyperandrogenism and polycystic ovary syndrome in women with type 1 diabetes mellitus,” Journal of Clinical Endocrinology and Metabolism, vol. 92, no. 4, pp. 1209–1216, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. R. L. Rosenfield, “Clinical review: adolescent anovulation-maturational mechanisms and implications,” Journal of Clinical Endocrinology and Metabolism, vol. 98, no. 9, pp. 3572–3583, 2013. View at Publisher · View at Google Scholar · View at Scopus